Nexentis Technologies (NXTS) Liabilities and Shareholders Equity (2018 - 2026)
Nexentis Technologies' Liabilities and Shareholders Equity came in at $18.69 million for Q2 2026, up 141.1% from $7.75 million a year earlier.
Nexentis Technologies (NXTS) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Nexentis Technologies' Liabilities and Shareholders Equity was $20.41 million, up 273.4% from FY2024.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 97.0% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $5.47 million in FY2024 (-24.6%), $7.24 million in FY2023 (+11.6%), $6.49 million in FY2022 (-14.5%) and $7.6 million in FY2021.
- The five-year range for quarterly Liabilities and Shareholders Equity is $5.25 million (Q3 2023) to $20.41 million (Q4 2025).
- Year-over-year, Liabilities and Shareholders Equity increased in six of the last seven quarters, with growth averaging 73.1%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2022 (growth of 651.6%), and the weakest in Q2 2022 (a decline of 47.5%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Nexentis Technologies | 1.13 Mn | -21.63 Mn | - | 18.69 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.69 Mn |
| Dec 31, 2025 | 20.41 Mn |
| Sep 30, 2025 | 11.03 Mn |
| Jun 30, 2025 | 7.75 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 5.82 Mn |
| Jun 30, 2024 | 7.48 Mn |
| Mar 31, 2024 | 6.27 Mn |
| Dec 31, 2023 | 7.24 Mn |
| Sep 30, 2023 | 5.25 Mn |
| Jun 30, 2023 | 6.16 Mn |
| Mar 31, 2023 | 5.47 Mn |
| Dec 31, 2022 | 6.49 Mn |
| Sep 30, 2022 | 7.89 Mn |
| Jun 30, 2022 | 5.39 Mn |
| Mar 31, 2022 | 6.62 Mn |
| Dec 31, 2021 | 7.60 Mn |
| Sep 30, 2021 | 8.84 Mn |
| Jun 30, 2021 | 10.27 Mn |
Nexentis Technologies Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NXTS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();